ad image

EXUMA Biotechnology

1 / 1
EXUMA Biotechnology
Clinical Trials

EXUMA Biotech Announces Phase 1 Results for its Autologous HER2 Directed CAR-T Product at ASCO GI 2025

EXUMA Biotechnology

PR-01-25-NI-26Feb 11, 2025
2021 Roundup: The Year of Cell and Gene Therapy

2021 Roundup: The Year of Cell and Gene Therapy

David Alvaro, Ph.D.

Pharma's Almanac

PA734Dec 20, 2021
Economically Viable, Same-Day Autologous Cell Therapies
Cell Therapy

Economically Viable, Same-Day Autologous Cell Therapies

Gregory Frost, Ph.D.; Sid Kerkar, M.D.

EXUMA Biotechnology

PAO-01-21-CL-06Feb 04, 2021
1 / 1